Paper36970219
Nucleic acid nanoassembly-enhanced RNA therapeutics and diagnosis.
Zhao M and 8 others. Acta Pharm Sin B, 2023. Cited by 80 papers, by iCite.
Cite this record
ConductScience Library. Nucleic acid nanoassembly-enhanced RNA therapeutics and diagnosis. Papers, record 36970219. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36970219
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References296
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32589345 | Tetrahedral DNA nanostructures as drug delivery and bioimaging platforms in cancer therapy. | Cancer Sci | 2020 | https://conductscience.org/library/papers/32589345 | PubMed |
| 2 | 34170121 | Spherical Nucleic Acids for Near-Infrared Light-Responsive Self-Delivery of Small-Interfering RNA and Antisense Oligonucleotide. | ACS Nano | 2021 | https://conductscience.org/library/papers/34170121 | PubMed |
| 3 | 24328173 | Development and characterization of gene silencing DNA cages. | Biomacromolecules | 2014 | https://conductscience.org/library/papers/24328173 | PubMed |
| 4 | 34654430 | Ginsenosides emerging as both bifunctional drugs and nanocarriers for enhanced antitumor therapies. | J Nanobiotechnology | 2021 | https://conductscience.org/library/papers/34654430 | PubMed |
| 5 | 23934178 | High-throughput profiling of off-target DNA cleavage reveals RNA-programmed Cas9 nuclease specificity. | Nat Biotechnol | 2013 | https://conductscience.org/library/papers/23934178 | PubMed |
| 6 | 8760800 | Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo. | J Exp Med | 1996 | https://conductscience.org/library/papers/8760800 | PubMed |
| 7 | 31951421 | Ionizable Lipid Nanoparticle-Mediated mRNA Delivery for Human CAR T Cell Engineering. | Nano Lett | 2020 | https://conductscience.org/library/papers/31951421 | PubMed |
| 8 | 23700324 | MicroRNA biomarkers in glioblastoma. | J Neurooncol | 2013 | https://conductscience.org/library/papers/23700324 | PubMed |
| 9 | 21102465 | The emerging field of RNA nanotechnology. | Nat Nanotechnol | 2010 | https://conductscience.org/library/papers/21102465 | PubMed |
| 10 | 33465863 | Self-assembled DNA-Guided RNA Nanovector via Step-wise Dual Enzyme Polymerization (SDEP) for Carrier-free siRNA Delivery. | ACS Biomater Sci Eng | 2016 | https://conductscience.org/library/papers/33465863 | PubMed |
| 11 | 24440746 | A practical approach for the detection of DNA nanostructures in single live human cells by fluorescence microscopy. | Methods | 2014 | https://conductscience.org/library/papers/24440746 | PubMed |
| 12 | 10602021 | In vivo application of RNA leads to induction of specific cytotoxic T lymphocytes and antibodies. | Eur J Immunol | 2000 | https://conductscience.org/library/papers/10602021 | PubMed |
| 13 | 11139616 | TectoRNA: modular assembly units for the construction of RNA nano-objects. | Nucleic Acids Res | 2001 | https://conductscience.org/library/papers/11139616 | PubMed |
| 14 | 28835943 | DNA tetrahedron nanostructures for biological applications: biosensors and drug delivery. | Analyst | 2017 | https://conductscience.org/library/papers/28835943 | PubMed |
| 15 | 32895504 | A DNA nanodevice-based vaccine for cancer immunotherapy. | Nat Mater | 2021 | https://conductscience.org/library/papers/32895504 | PubMed |
| 16 | 11231555 | Inhibition of gene expression in Entamoeba histolytica with antisense peptide nucleic acid oligomers. | Nat Biotechnol | 2001 | https://conductscience.org/library/papers/11231555 | PubMed |
| 17 | 31490470 | Dual amplification ratiometric biosensor based on a DNA tetrahedron nanostructure and hybridization chain reaction for the ultrasensitive detection of microRNA-133a. | Chem Commun (Camb) | 2019 | https://conductscience.org/library/papers/31490470 | PubMed |
| 18 | 31085078 | Delivery of Anti-miRNA for Triple-Negative Breast Cancer Therapy Using RNA Nanoparticles Targeting Stem Cell Marker CD133. | Mol Ther | 2019 | https://conductscience.org/library/papers/31085078 | PubMed |
| 19 | 33121373 | To Conjugate or to Package? A Look at Targeted siRNA Delivery Through Folate Receptors. | Nucleic Acid Ther | 2021 | https://conductscience.org/library/papers/33121373 | PubMed |
| 20 | 24840462 | Quantitative single-molecule detection of protein based on DNA tetrahedron fluorescent nanolabels. | Talanta | 2014 | https://conductscience.org/library/papers/24840462 | PubMed |
Cited by45
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 80 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42948368 | Ultra-sensitive detection of receptor binding domain of SARS-CoV-2 based on artificial intelligence assisted antibody selection and antibody‒nucleic acid conjugation signal amplification. | Acta Pharm Sin B | 2026 | https://conductscience.org/library/papers/42948368 | PubMed |
| 42632941 | Advances in gene transfer technologies: comparing viral and non-viral vectors for therapeutic applications. | 3 Biotech | 2026 | https://conductscience.org/library/papers/42632941 | PubMed |
| 42222368 | RNA editing in Parkinson's disease: emerging mechanisms, translational potential, and current challenges. | Front Neurosci | 2026 | https://conductscience.org/library/papers/42222368 | PubMed |
| 41754905 | Nanotechnology-Enabled Precision Therapy for Lung Cancer in Never-Smokers. | Pharmaceutics | 2026 | https://conductscience.org/library/papers/41754905 | PubMed |
| 41477346 | m6A readers: Promising therapeutic targets in cancer treatment. | Acta Pharm Sin B | 2025 | https://conductscience.org/library/papers/41477346 | PubMed |
| 41163434 | The Use of Enhanced Analytical Pipelines for the Characterization of Poly(A) and Poly(A)-LNP Formulation Critical Quality Attributes. | Mol Pharm | 2025 | https://conductscience.org/library/papers/41163434 | PubMed |
| 41090155 | Gene and RNA Editing: Revolutionary Approaches to Treating Diseases. | MedComm (2020) | 2025 | https://conductscience.org/library/papers/41090155 | PubMed |
| 40864160 | Polyphenol-Based Functional Materials: Structural Insights, Composite Strategies, and Biomedical Applications. | Adv Sci (Weinh) | 2025 | https://conductscience.org/library/papers/40864160 | PubMed |
| 40771758 | Bioactive Nanomaterials: Comprehensive Monitoring and Regulation of Acute Pancreatitis Induced Acute Lung Injury. | Int J Nanomedicine | 2025 | https://conductscience.org/library/papers/40771758 | PubMed |
| 40612625 | Membrane-modified lipid nanoparticles for RNA delivery. | Mol Ther Methods Clin Dev | 2025 | https://conductscience.org/library/papers/40612625 | PubMed |
| 40594473 | Comprehensive datasets for RNA design, machine learning, and beyond. | Sci Rep | 2025 | https://conductscience.org/library/papers/40594473 | PubMed |
| 40071030 | Peptides: potential delivery systems for mRNA. | RSC Chem Biol | 2025 | https://conductscience.org/library/papers/40071030 | PubMed |
| 40065832 | Biomaterials for Modulating the Immune Microenvironment in Rheumatoid Arthritis. | BME Front | 2025 | https://conductscience.org/library/papers/40065832 | PubMed |
| 39844156 | PLGA confers upon conventional nonfluorescent molecules luminescent properties to trigger 1O2-induced pyroptosis and immune response in tumors. | J Nanobiotechnology | 2025 | https://conductscience.org/library/papers/39844156 | PubMed |
| 39769985 | Hybrid RNA/DNA Concatemers and Self-Limited Complexes: Structure and Prospects for Therapeutic Applications. | Molecules | 2024 | https://conductscience.org/library/papers/39769985 | PubMed |
| 39759971 | Machine learning-driven optimization of mRNA-lipid nanoparticle vaccine quality with XGBoost/Bayesian method and ensemble model approaches. | J Pharm Anal | 2024 | https://conductscience.org/library/papers/39759971 | PubMed |
| 39312148 | Datasets for Benchmarking RNA Design Algorithms. | Methods Mol Biol | 2025 | https://conductscience.org/library/papers/39312148 | PubMed |
| 39309508 | Current status and trends in small nucleic acid drug development: Leading the future. | Acta Pharm Sin B | 2024 | https://conductscience.org/library/papers/39309508 | PubMed |
| 39263430 | Therapeutic applications of RNA nanostructures. | RSC Adv | 2024 | https://conductscience.org/library/papers/39263430 | PubMed |
| 39050960 | Revolutionizing cancer therapy using tetrahedral DNA nanostructures as intelligent drug delivery systems. | Nanoscale Adv | 2024 | https://conductscience.org/library/papers/39050960 | PubMed |
Genes18
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36970219
GET https://conductscience.org/api/papers/v1/36970219/references?page=2